42 filings
S-8
APGE
Apogee Therapeutics Inc.
13 May 24
Registration of securities for employees
7:26am
10-Q
2024 Q1
APGE
Apogee Therapeutics Inc.
Quarterly report
13 May 24
7:10am
8-K
APGE
Apogee Therapeutics Inc.
13 May 24
Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
7:05am
ARS
2023 FY
APGE
Apogee Therapeutics Inc.
24 Apr 24
Annual report to shareholders
4:18pm
DEFA14A
APGE
Apogee Therapeutics Inc.
24 Apr 24
Additional proxy soliciting materials
4:16pm
DEF 14A
nk3m9q t30
24 Apr 24
Definitive proxy
4:15pm
8-K
nchi04c5vkn
25 Mar 24
Regulation FD Disclosure
7:30am
424B4
efrvzwaj44r9mxhdklol
11 Mar 24
Prospectus supplement with pricing info
6:01am
EFFECT
0irqb9wri
8 Mar 24
Notice of effectiveness
12:15am
S-1MEF
dt4wnfjhvybeqvb8g
7 Mar 24
Registration of additional securities for an S-1
6:27pm
8-K
xx3z9jv7 ao5d5
5 Mar 24
Regulation FD Disclosure
8:15am
10-K
sjf uvx8slrsk
5 Mar 24
Annual report
6:15am
8-K
0pn7 visrmu9plt3l
5 Mar 24
Apogee Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
6:11am
DRS
h5j7ap
9 Feb 24
Draft registration statement
12:00am
8-K
xz83mw b6irz
13 Nov 23
Apogee Highlights Corporate Progress and Reports Third Quarter 2023 Financial Results
7:41am
S-8
2zxok60ivavw02r0np
28 Aug 23
Registration of securities for employees
8:38am
10-Q
ke5eyxujipu
28 Aug 23
Quarterly report
8:00am
8-K
bnm1ih 2d
28 Aug 23
Apogee Highlights Corporate Progress and Reports Second Quarter 2023 Financial Results
7:35am